1990
DOI: 10.1016/0006-2952(90)90433-l
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of tyrosine-3-monooxygenase by benserazide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1991
1991
1996
1996

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 12 publications
0
3
0
Order By: Relevance
“…Most of the strong TrpH inhibitors known are potential iron chelators, consistent with an essential role for the iron, as was discussed in section II.C.4. Generally, the inhibitors of this type that are of physiological interest are catechols, like the l -Dopa-derived TyrH catecholamine products or other compounds, such as benserazide, a catechol used in combination with l -Dopa as a Parkinson's treatment (Medopar). ,,,, Benserazide is competitive vs BH 4 ( K I = 80 ± 10 μM) and uncompetitive vs l -Trp ( K I = 176 ± 13 μM); similar results were obtained with TyrH . This result implies that this catechol and l -Trp do not bind the same form of TrpH; if benserazide binds to the free enzyme only, this could indicate some degree of order in the sequential mechanism.…”
Section: Trphmentioning
confidence: 56%
See 1 more Smart Citation
“…Most of the strong TrpH inhibitors known are potential iron chelators, consistent with an essential role for the iron, as was discussed in section II.C.4. Generally, the inhibitors of this type that are of physiological interest are catechols, like the l -Dopa-derived TyrH catecholamine products or other compounds, such as benserazide, a catechol used in combination with l -Dopa as a Parkinson's treatment (Medopar). ,,,, Benserazide is competitive vs BH 4 ( K I = 80 ± 10 μM) and uncompetitive vs l -Trp ( K I = 176 ± 13 μM); similar results were obtained with TyrH . This result implies that this catechol and l -Trp do not bind the same form of TrpH; if benserazide binds to the free enzyme only, this could indicate some degree of order in the sequential mechanism.…”
Section: Trphmentioning
confidence: 56%
“…332,373,818,832,833 Benserazide is competitive vs BH 4 (K I ) 80 ( 10 µM) and uncompetitive vs L-Trp (K I ) 176 ( 13 µM); 367 similar results were obtained with TyrH. 834 This result implies that this catechol and L-Trp do not bind the same form of TrpH; if benserazide binds to the free enzyme only, this could indicate some degree of order in the sequential mechanism.…”
Section: Trphmentioning
confidence: 76%
“…Ro 4-4602 inhibits TH and tryptophan hydroxylase (EC I . 14.16.4) (Reinhard and Shearin, 1990;Johansen et al, I99 I), whereas NSD 10 15 has a mild M A 0 inhibitory effect (Carlsson et al, 1972). Moreover, the fluorinated analogues of DOPA do not produce other nonspecific actions such as reserpinelike monoamine depletion, inhibition of monoamine uptake, antagonism of adrenoceptors, or irreversible inhibition of catechol-0-methyltransferase (COMT; EC 2.1.1.6) (Jung et al, 1979a,b;Fozard et al, 1980;Palfreyman et al, 1984).…”
Section: Interest Of Dfmd As An Aadc Inhibitormentioning
confidence: 99%